Indoco Remedies profit increased 217.91% in (Q1) FY 2020-21

Source

Team Infinities:

Indoco Remedies Limited NSE Symbol:INDOCO, BSE Security Code:532612 has declared its 1st(first) quarter un-audited Consolidated financial report from the month of April, 2020 to the month of June, 2020; for the fiscal year 2020-21.

Revenue Reported by Indoco Remedies Limited for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020) Previous Quarter (January, 2020 - March, 2020) Corresponding Quarter (April, 2019 - June, 2019)
276.12 272.49 253.31
Calculated Revenue of Indoco Remedies Limited for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020) Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
3.63 1.33%(Revenue Increase) 22.81 9.00%(Revenue Increase)

Revenue: Indoco Remedies Limited's financial report shows that the company's revenue increased by 1.33% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for revenue increase of Rs.3.63 crores, as the company posted revenue of Rs.276.12 crores; in compare to previous quarter(January, 2020 - March, 2020) when the company reported revenue of Rs.272.49 crores.
The result also shows that the company's revenue increased by 9.00% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for revenue increase of Rs.22.81 crores; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted revenue of Rs.253.31 crores.

Gross Margin(%) Reported by Indoco Remedies Limited for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020) Previous Quarter (January, 2020 - March, 2020) Corresponding Quarter (April, 2019 - June, 2019)
70.83 70.93 69.42
Calculated Gross Margin(%) of Indoco Remedies Limited for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020) Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
0.10 0.14%(GM Decrease) 1.41 2.03%(GM Increase)

Gross Margin(%)/ GM: The company's financial report indicates, the company's GM decreased by 0.14% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for 0.10% GM decrease, as the company reported 70.83% GM; in compare to previous quarter(January, 2020 - March, 2020) when the company reported 70.93% GM.
The result also indicates, the company's GM increased by 2.03% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for 1.41% GM increase; in compare to corresponding quarter(April, 2019 - June, 2019) when the company reported 69.42% GM.

EBITDA Reported by Indoco Remedies Limited for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020) Previous Quarter (January, 2020 - March, 2020) Corresponding Quarter (April, 2019 - June, 2019)
48.91 33.79 23.06
Calculated EBITDA of Indoco Remedies Limited for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020) Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
15.12 44.75%(EBITDA Increase) 25.85 112.10%(EBITDA Increase)

EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA increased by 44.75% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for EBITDA increase of Rs.15.12 crores, as the company posted EBITDA of Rs.48.91 crores; in compare to previous quarter(January, 2020 - March, 2020) when the company reported EBITDA of Rs.33.79 crores.
The result also shows that the company's EBITDA increased by 112.10% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for EBITDA increase of Rs.25.85 crores; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted EBITDA of Rs.23.06 crores.

Profit and Loss Reported by Indoco Remedies Limited for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020) Previous Quarter (January, 2020 - March, 2020) Corresponding Quarter (April, 2019 - June, 2019)
17.04(Profit ) 5.36(Profit ) 1.85(Profit )
Calculated Profit and Loss of Indoco Remedies Limited for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020) Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
11.68 217.91%(Profit Increase) 15.19 821.08%(Profit Increase)

Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit increased by 217.91% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for profit increase of Rs.11.68 crores, as the company posted profit of Rs.17.04 crores; in compare to previous quarter(January, 2020 - March, 2020) when the company reported profit of Rs.5.36 crores.
The result also shows that the company's profit increased by 821.08% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for profit increase of Rs.15.19 crores; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted profit of Rs.1.85 crores.

EPS Reported by Indoco Remedies Limited for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020) Previous Quarter (January, 2020 - March, 2020) Corresponding Quarter (April, 2019 - June, 2019)
1.85 0.58 0.20
Calculated EPS of Indoco Remedies Limited for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020) Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
1.27 218.97%(EPS Increase) 1.65 825.00%(EPS Increase)

EPS /Earning per Share: The company's financial report shows that the company's EPS increased by 218.97% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for EPS increase of Rs.1.27, as the company posted EPS of Rs.1.85; in compare to previous quarter(January, 2020 - March, 2020) when the company reported EPS of Rs.0.58.
The result also shows that the company's EPS increased by 825.00% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for EPS increase of Rs.1.65; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted EPS of Rs.0.20.

 


***All amounts are given in Crore Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.

 

Add new comment

Comment Editor

  • No HTML tags allowed.